๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Cetuximab

Comparing Efficacy and Safety of Enlituoยฎ Versus Erbituxยฎ Plus FOLFOX in Locally Advanced/Metastatic Colorectal Cancer With RAS/BRAF Wild-type and MSS/pMMR Status. NCT07595276Phase 31 site๐Ÿ“ Guangzhou Taizhou Mabtech Pharmaceutical Co.,Ltd ยท Tests: Enlituoยฎ, Erbituxยฎ Study to Evaluate the Efficacy and Safety of Cetuximab in Combination with Encorafenib Plus Binimetinib As Induction Treatment in BRAF V600E Mutated MSS Initially Resectable or Potentially Resectable Advanced Colorectal Cancer NCT06207656Phase 21 site๐Ÿ“ Madrid Spanish Cooperative Group for the Treatment of Digestive Tuโ€ฆ ยท Tests: EBC Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab NCT06540326Phase 21 site๐Ÿ“ Hangzhou Second Affiliated Hospital, Zhejiang University, School of โ€ฆ ยท Tests: irinotecan liposome (II), fluorouracil, cetuximab, bevacizumab, Capecitabine New Second-Line Combo Therapy for MSS Metastatic Colorectal Cancer NCT07559760Phase 21 site๐Ÿ“ Changchun The First Hospital of Jilin University ยท Tests: Levofolinic Acid + 5-FU continuous infusion + irinotecan HCl liposome ยฑ cetuximab/bevacizumab BBO-11818 in Adult Subjects With KRAS Mutant Cancer NCT06917079Phase 117 sites๐Ÿ“ Los Angeles๐Ÿ“ Sacramento๐Ÿ“ San Diego TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) ยท Tests: BBO-11818, Pembrolizumab, Platinum chemotherapy (cisplatin or carboplatin), Pemetrexed, Cetuximab A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014) NCT07209111Phase 272 sites๐Ÿ“ Baltimore๐Ÿ“ Grand Rapids๐Ÿ“ Las Vegas Merck Sharp & Dohme LLC ยท Tests: Calderasib, Cetuximab Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1) NCT07702032Phase 38 sites๐Ÿ“ Hot Springs๐Ÿ“ Los Angeles๐Ÿ“ Savannah Genmab ยท Tests: Petosemtamab, Cetuximab, FOLFIRI, mFOLFOX6 Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Advanced Head and Neck Cancer Who Cannot Receive Cisplatin NCT07441681Phase 3150 sites๐Ÿ“ Birmingham๐Ÿ“ Anaheim๐Ÿ“ Baldwin Park NRG Oncology ยท Tests: Biospecimen Collection, Carboplatin, Cetuximab, Computed Tomography, Intensity-Modulated Radiation Therapy Study of TPEx Followed by a Maintenance With Avelumab and Cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma of the H&N NCT06640725Phase 21 site๐Ÿ“ Vandล“uvre-lรจs-Nancy Groupe Oncologie Radiotherapie Tete et Cou ยท Tests: Avelumab administration at 10mg/kg, Cetuximab (Erbitux) FOLFOX-HAIC as Conversion Treatment for Initially Unresectable Colorectal Liver Metastasis NCT06988852Phase 21 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: FOLFOX (oxaliplatin, leucovorin, 5-fluorouracil [5FU]), hepatic arterial infusion chemotherapy (HAIC), Bevacizumab, Cetโ€ฆ Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System NCT07042295Phase 255 sites๐Ÿ“ Birmingham๐Ÿ“ Gilbert๐Ÿ“ La Jolla National Cancer Institute (NCI) ยท Tests: Amivantamab and Recombinant Human Hyaluronidase, Biospecimen Collection, Cetuximab, Computed Tomography, Magnetic Resonโ€ฆ A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation NCT07535112Phase 121 sites๐Ÿ“ Phoenix๐Ÿ“ Duarte๐Ÿ“ San Diego Bayer ยท Tests: BAY 3771249, Cetuximab A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer NCT07474727Phase 219 sites๐Ÿ“ Fuzhou๐Ÿ“ Nanning๐Ÿ“ Guangzhou Multitude Therapeutics Inc. ยท Tests: AMT-676, 5-FU, Leucovorin, Bevacizumab, Cetuximab Toripalimab Plus Cetuximab and Irinotecan for Second-Line Right-Sided RAS/BRAF Wild-Type Advanced Colon Cancer Phase II Study NCT07896681Phase 21 site๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: Toripalimab, Cetuximab, Irinotecan The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer NCT07204574Phase 1, Phase 21 site๐Ÿ“ Taoyuan Chang Gung Memorial Hospital ยท Tests: HCB101, Bevacizumab, Cetuximab (Erbitux), FOLFIRI (Fluorouracil (5-FU), leucovorin, irinotecan), FOLFOX (Oxaliplatin/Leโ€ฆ A Study of GFH375 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors Harboring KRAS G12D Mutation NCT07259590Phase 1, Phase 24 sites๐Ÿ“ Beijing๐Ÿ“ Guangzhou๐Ÿ“ Zhengzhou Genfleet Therapeutics (Shanghai) Inc. ยท Tests: GFH375, GFH375 Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age NCT05956821Phase 1, Phase 21 site๐Ÿ“ Miami University of Miami ยท Tests: SIACI of cetuximab and bevacizumab IBI351 Plus Cetuximab ฮฒ in Untreated Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation NCT07198841Phase 27 sites๐Ÿ“ Guangzhou๐Ÿ“ Beijing๐Ÿ“ Foshan Guangdong Association of Clinical Trials ยท Tests: IBI351 combined with cetuximab ฮฒ A Clinical Study of Arfolitixorin in Patients With mCRC NCT06922383Phase 1, Phase 23 sites๐Ÿ“ Berlin๐Ÿ“ Essen๐Ÿ“ Mรผnchen Isofol Medical AB ยท Tests: Arfolitixorin, Leucovorin A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation NCT07678593Phase 1, Phase 217 sites๐Ÿ“ Concord๐Ÿ“ North Ryde๐Ÿ“ Woodville South Genfleet Therapeutics (Shanghai) Inc. ยท Tests: GFH276, Cetuximab, Nab paclitaxel, Gemcitabine, Fluorouracil Cetuximab Combined With Pembrolizumab or Finotonlimab and Chemotherapy in R/M HNSCC NCT07509099Phase 32 sites๐Ÿ“ Shanghai๐Ÿ“ Shanghai Ji Dongmei ยท Tests: cetuximab+PD-1 mAb(Pembrolizumab/Finotonlimab)+chemotherapy, PD-1 mAb (Pembrolizumab/Finotonlimab) + chemothearpy Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer NCT06369259Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Defactinib, Cetuximab, Avutometinib Neoadjuvant PD-1 Inhibitor Combined With Cetuximab and Platinum in Resectable Locally Advanced Hypopharyngeal Carcinoma NCT06151743Phase 21 site๐Ÿ“ Shanghai Eye & ENT Hospital of Fudan University ยท Tests: three cycles (toripalimab + cetuximab + platinum), Radical surgery, Radiotherapy or chemoradiotherapy Cetuximab Plus Irinotecan in Patients With NeoRAS Wild-type Metastatic Colorectal Cancer In Third-line Therapy NCT05962502Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Cetuximab and irinotecan Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer NCT05959356Phase 23 sites๐Ÿ“ Foshan๐Ÿ“ Guangzhou๐Ÿ“ Guiyang Sun Yat-sen University ยท Tests: Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6 Cetuximab Plus Platinum and Taxane-based Chemotherapy, Followed by Avelumab and Cetuximab, as First-line Treatment for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Patients With a PD-L1 Combined Positive Score (CPS)โ‰ฅ1โ‰ค19. NCT06869473Phase 28 sites๐Ÿ“ Cagliari๐Ÿ“ Catania๐Ÿ“ Florence Gruppo Oncologico del Nord-Ovest ยท Tests: Cetuximab/avelumab A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012) NCT06997497Phase 3244 sites๐Ÿ“ Phoenix๐Ÿ“ Fountain Valley๐Ÿ“ Los Angeles Merck Sharp & Dohme LLC ยท Tests: Calderasib, Oxaliplatin, Leucovorin/levofolinate calcium, 5-Fluorouracil, Cetuximab ROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer" NCT07381764Phase 226 sites๐Ÿ“ Alessandria๐Ÿ“ Ancona๐Ÿ“ Aviano Gruppo Oncologico Italia Meridionale ยท Tests: Erbitux (Cetuximab), Bevacizumab, Irinotecan, Trifluridine/tipiracil Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA NCT02800486Phase 21 site๐Ÿ“ New York Northwell Health ยท Tests: Intra-arterial Cetuximab, Intra-arterial Mannitol, Hypofractionated re-irradiation A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy NCT06750094Phase 3251 sites๐Ÿ“ Chandler๐Ÿ“ Gilbert๐Ÿ“ Prescott Janssen Research & Development, LLC ยท Tests: Amivantamab, Cetuximab, Bevacizumab, 5-fluorouracil, Leucovorin calcium/Levoleucovorin
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy